Skip to main content

What is #4Chords4Cancer?

What is #4Chords4Cancer?


A community of musicians and music-lovers around the world is coming together to spread awareness of the free resources available to people with cancer and their loved ones.

This year alone, it is estimated that 1.6 million people in the US will be diagnosed with cancer. In fact, 41% of Americans are expected to receive a cancer diagnosis in their lifetime, which translates to 1 in 3 women and 1 in 2 men. A cancer diagnosis is a life changing event that often brings with it feelings of anxiety, distress and depression. We firmly believe that these feelings are something that no one should have to go through alone.

The Cancer Support Community, in partnership with healtheo360, an online patient and caregiver support community, has launched #4Chords4Cancer—a campaign to let everyone going through cancer know that they are not alone.

Thanks to the generous donations of Martin Guitar and Dave Nichols of Custom Pearl Inlay, a beautiful acoustic guitar is making its way across the country to gather the autographs of musicians all over the country who are sharing their stories on social media with the hashtag #4Chords4Cancer.

This spring, after gathering the signatures of musicians all over the country, the guitar will be auctioned off at the Cancer Support Community’s annual Spring Celebration gala in New York City to raise vital funds to support our many programs—all provided free of charge to families impacted by cancer.


Here are 4 steps to join us!

1. Play four chords on your instrument of choice and upload a photo or video of yourself.

2. Share with the hashtag #4Chords4Cancer on Instagram, Twitter or Facebook in honor or in memory of someone you love.

3. Encourage your friends and family to spread the word and support people facing cancer.

4. Give a donation to help the Cancer Support Community reach more people who need support.

Follow the guitar on social media with the hashtag #4Chords4Cancer, and check back here for more updates.